Evaluation of Tebipenem Activity Tested against a Collection of Isogenic Escherichia coli Strains Producing Various Clinically Relevant β-lactamases Posted on June 24, 2019 at 3:13 pm.Written by Spero Therapeutics View Presentation Post navigation Tebipenem: Oral Carbapenem for the Treatment of Complicated Urinary Tract Infections – Oral PresentationThe burden of resistance among urinary tract isolates of Escherichia coli in the United States in 2017
